References
- Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
- Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 2010;17:194–203
- Bozkurt N, Ozkan S, Korucuoglu U, et al. Urogenital symptoms of postmenopausal women in Turkey. Menopause 2007;14:150–6
- Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:46–52
- Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol 1981;141:817–20
- Hassa H, Tanir HM, Oge T. Is placebo as effective as estrogen regimens on vasomotor symptoms in women with surgical menopause?Clin Exp Obstet Gynecol 2010;37:135–7
- Hassa H, Tanir HM, Tekin B, Senses T, Oge T, Mutlu FS. Possible factors affecting the age at menopause among women in the central anatolian region of Turkey. Clin Exp Obstet Gynecol 2006;33:59–60
- Hassa H, Tanir HM, Yildirim A, Senses T, Oge T, Mutlu FS. Associated factors with urogenital score in natural and surgical menopause. Maturitas 2005;52:65–9
- Davila G, Singh A, Karapanagiotou I, et al. Are women with urogenital atrophy symptomatic?. Am J Obstet Gynecol 2003;188:382–8
- Canario AC, Cabral PU, Spyrides MH, Giraldo PC, Eleuterio J Jr, Goncalves AK. The impact of physical activity on menopausal symptoms in middle-aged women. Int J Gynaecol Obstet 2012;118:34–6
- Blümel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85
- Archer DF, Sturdee DW, Baber R, et al. Menopausal hot flushes and night sweats: where are we now?. Climacteric 2011;14:515–28
- Hickey M, Bryant C, Judd F. Evaluation and management of depressive and anxiety symptoms in midlife. Climacteric 2012;15:3–9
- Woods NF, Smith-Dijulio K, Percival DB, Tao EY, Taylor HJ, Mitchell ES. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women’s Health Study. J Womens Health 2007;16:667–77
- Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
- Baden WF, Walker TA. Genesis of the vaginal profile: a correlated classification of vaginal relaxation. Clin Obstet Gynecol 1972;15:1048–54
- van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179–83
- Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas 2004;49:292–303
- Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87–91
- Thor KB, Kirby M, Viktrup L. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int J Clin Pract 2007;61:1349–55
- Alexander IM, Moore A. Treating vasomotor symptoms of menopause: the nurse practitioner’s perspective. J Am Acad Nurse Pract 2007;19:152–63
- Rajaofetra N, Passagia JG, Marlier L, et al. Serotoninergic, noradrenergic, and peptidergic innervation of Onuf’s nucleus of normal and transected spinal cords of baboons (Papio papio). J Comp Neurol 1992;318:1–17